A pan-European radiotherapy provider is planning to pull out of Poland, after arguing with the country's NHS. HBI speaks to the plain-speaking founding partner as he closes one of its two centres, and invites bids on the other.
The departure of the UAE's highest-paid expat segment may soon start to hit the private hospital sector, we are told, and some providers may stand to lose more than others.
UK-based Proton Partners made a loss of £22m in the first FY since it moved to an operational model. HBI speaks to CEO Mike Moran to speak about growth, its NEX listing and troubled-investor Neil Woodford.
Pan-Asian hospital group IHH Healthcare has announced its CEO will change at the end of 2019, a refinancing of up to $250m of non-Lira debt and its Fortis deal boosted Q1 2019 results, while its Turkish subsidiary Acibadem is reportedly eyeing an investment in London.
Private Healthcare Information Network (Phin) has published data on consultant physician fees in the private sector in the UK for the first time. So how close are we to really clear comparisons on price and quality between for-profit operators and on quality between the for-profit and NHS?
The French lab market contracted by 0.5% in 2018 as its public payor (CNAM) cut the national tariff to offset volume increases. HBI reveals how the country's largest groups faired.
With several significant withdrawals by developed markets operators and the collapse of Abraaj in 2018, what does the emerging markets investment landscape look like? Investors focusing on Asia and Latin America discussed the challenges and opportunities at HBI 2019.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.